BU-NOT-SET

CONTACT US
Nitrosamines analysis
  • Analytical chemistry
Nitrosamines analysis
Fact sheet
Enabling oral solid dosage form delivery of biologics
  • Biologics
  • Drug substance
oral biologics
Insight
Plasmid DNA manufacturing capabilities
  • Biologics
plasmid DNA manufacturing
Fact sheet
Leveraging analytics throughout development and manufacture to achieve commercial success
  • Analytical chemistry
  • Drug substance
development
Insight
2,300 solar panels installed at Recipharm’s Holmes Chapel
  • Sustainability
solar panels
Insight
Analysing prebiotic oligosaccharides for future product innovation
  • Analytical chemistry
  • Drug substance
Workers
White paper
Enhancing sterile processing for future vaccine programs
  • Industry trends
  • Manufacturing
Manufacturing
Insight
Increasing carbon emission transparency through SBTi contributions
  • Sustainability
SBTi
Insight
Single-use technologies are enabling increasing demand for biologics
  • Biologics
People
Insight
Insight
  • Manufacturing
Countdown to EU FMD deadline
Fact sheet
  • Manufacturing
Stand-alone serialisation services
Insight
  • Industry trends
Post-Brexit medicines - stuck in the UK?
Insight
  • Industry trends
Brexit: What will it mean for the regulation of medicines?
Insight
  • Analytical chemistry
Stability study trends - Outsourcing stability studies
Insight
  • Industry trends
The EMA relocation: Brexit and the UK's pharmaceutical industry
Insight
  • Drug product
Prevention not cure: avoiding a European prescription opioid epidemic
Insight
  • Manufacturing
Six months and counting: industry views
Insight
  • Manufacturing
Six months until DSCSA… industry comments